Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival
Glen Kristiansen, Christian Pilarsky, Christoph Wissmann, Simone Kaiser, Thomas Bruemmendorf, Stefan Roepcke, Edgar Dahl, Bernd Hinzmann, Thomas Specht, Janja Pervan, Carsten Stephan, Stefan Loening,Volume:
205
Année:
2005
Langue:
english
Pages:
18
DOI:
10.1002/path.1676
Fichier:
PDF, 806 KB
english, 2005